Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) Inspection Information
Inspections Performed in Fiscal Years 2018 to 2022
Inspection Conclusion by Fiscal Year
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Inspections Classified NAI | 529 | 440 | 236 | 111 | 295 |
| Inspections Classified VAI | 93 | 111 | 40 | 44 | 73 |
| Inspections Classified OAI | 12 | 12 | 8 | 4 | 11 |
| Number of Inspections1 | 625 | 563 | 287 | 159 | 379 |
NAI = No Action Indicated, meaning no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further action).
VAI = Voluntary Action Indicated, meaning objectionable conditions were found and documented but the agency is not prepared to take or recommend regulatory action.
OAI = Official Action Indicated, meaning objectionable conditions were found and regulatory action should be recommended.
[1]Sum of inspection classifications does not equal total number of inspections performed by fiscal year due to data constraints.